Home » Topics » Regulatory » Patents

Patents
RSS

Novel therapeutic agents for transplant rejection disclosed by Astellas

Feb. 22, 2007

Novel therapeutic agents for respiratory disorders described in recent patents

Feb. 22, 2007

Novel anticancer compounds described in recent patents

Feb. 22, 2007

Recent Tibotec, Medivir and Valeant patents report novel anti-hepatitis agents

Feb. 22, 2007

AMR and Bristol-Myers Squibb patent discloses new agents for ADHD

Feb. 21, 2007

Novel agents for cardiovascular disorders disclosed in Vertex and Merck Frosst patents

Feb. 21, 2007

Novel metabolic drugs described in recent patent literature

Feb. 21, 2007

Recent patents disclose novel treatments for diabetes

Feb. 20, 2007

New agents for treating neurological disorders disclosed in recent patents

Feb. 20, 2007

Recent Nissan Chemical patents describe new treatment options for thrombocytopenia

Feb. 20, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...